<DOC>
	<DOCNO>NCT00642161</DOCNO>
	<brief_summary>A comparison safety , efficacy budesonide pharmacokinetics currently approve Pulmicort Turbuhaler new version inhaler , child adolescent asthma . In addition study evaluate functionality new inhaler end intend life .</brief_summary>
	<brief_title>New Version Pulmicort Turbuhaler USA Children</brief_title>
	<detailed_description />
	<mesh_term>Budesonide</mesh_term>
	<criteria>Male female age 6 17 diagnosis asthma least 3 month . Have use inhaled corticosteroid one month enter study none . A forced expiratory volume ( FEV1 ) 1 second 75 % 90 % predict normal age 6 11 60 % 90 % age 12 17 year . Airway reversibility least 12 % , use orally inhale corticosteroid one month immediately enter study none . Life threaten asthma , Two overnight hospitalisation asthma within 1 year emergency room visit asthma within 6 month start study . Use steroid tablet injection month prior Visit 1 use asthma medicine ( except rescue medication ) within 2 week prior study . Any acute exacerbation asthma respiratory tract infection within 30 day prior Visit 1 . Must smoke smoke .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Pulmicort</keyword>
	<keyword>Children</keyword>
	<keyword>Paediatrics</keyword>
	<keyword>budesonide</keyword>
	<keyword>Flexhaler</keyword>
</DOC>